Gastroenteritis
Gastroenteritis, also known as infectious diarrhea or gastro, is an inflammation of the gastrointestinal tract including the stomach and intestine, typically caused by viruses like norovirus. Symptoms, which may include diarrhea, vomiting, abdominal pain, fever, and dehydration, usually last up to 14 days.
Health Outcomes
- Accurate Enumeration of Viable Probiotic Bacteria
- Achieved Complete Symptom Cessation
- Activated Intestinal Immune Response
- Altered Gastrointestinal Health Post-Infection
- Antimicrobial Food Preservation
- Balanced Intestinal Microflora
- Binding to Goblet Cell Mucus
- Changed Stool Consistency
- Colonization of Gastrointestinal Tract by L. reuteri
- Colonization of the Intestine
- Complete Resolution of Abdominal Pain
- Confirmed Safety of Oral Probiotic Administration
- Detected Antimicrobial Resistance Genes
- Disrupted Bacterial Cell Membranes
- Downregulated Salmonella Virulence Genes
- Effective Gastroenteritis Treatment
- Effectiveness Compared to Commercial Probiotic
- Enhanced Anti-Salmonella Antibody Production
- Enhanced Digestive Process Survival
- Enhanced Food Safety
- Enhanced Gas Passing
- Enhanced Gastric Viability
- Enhanced Gastrointestinal Stress Resistance
- Enhanced Gut Probiotic Bacteria Propagation
- Enhanced Immune Response to Oral Inactivated Cholera Vaccine
- Enhanced Immunity to Intestinal Infections
- Enhanced Intestinal Barrier Function
- Enhanced Intestinal Defense Maturation
- Enhanced Intestinal Epithelial Maturation
- Enhanced Intestinal Innate Mucosal Immunity
- Enhanced Intestinal Mucosal Cell Protection
- Enhanced Mucosal Protection
- Enhanced Pathogen Protection
- Enhanced Probiotic Activity
- Enhanced Resistance to E. coli
- Enhanced Vagal Nerve Activity in the Stomach
- Enhanced Water Quality
- Gut Colonization by Saccharomyces boulardii
- Gut Localization of Lactobacillus brevis
- Improved Abdominal Pain
- Improved Abdominal Pain Severity
- Improved Anti-Microbial Activity Against Campylobacter Jejuni
- Improved Bloating
- Improved Diarrhea Symptoms
- Improved Digestive Health
- Improved Digestive Performance
- Improved Digestive Viability
- Improved Disease Resolution
- Improved Faecal Dry Matter
- Improved Food Safety
- Improved Gastrointestinal Discomfort
- Improved Gastrointestinal Function
- Improved Gastrointestinal Health
- Improved Gastrointestinal Infection Outcomes
- Improved Gastrointestinal Pathogen Inhibition
- Improved Gastrointestinal Recovery
- Improved Gastrointestinal Resilience
- Improved Gastrointestinal Resistance
- Improved Gastrointestinal Symptom Management
- Improved Gastrointestinal Symptom Rating Scale Score
- Improved Gastrointestinal Symptom Relief
- Improved Gastrointestinal Tolerance
- Improved Gastrointestinal Viability
- Improved Gastrointestinal Well-Being
- Improved General GI Health Status
- Improved Gut Barrier Function
- Improved Gut Dysbiosis
- Improved Gut Health (Lower Faecal pH)
- Improved Gut Inflammation
- Improved Gut Microbiome Recovery
- Improved Gut Microbiota Composition in Small Intestine
- Improved Gut Protection
- Improved Infant Gut Microbiota Restoration
- Improved Intestinal Defense
- Improved Intestinal Defense Mechanism
- Improved Intestinal Flora Balance
- Improved Intestinal Health Biomarkers During Infection
- Improved Intestinal Histomorphology
- Improved Intestinal Immune Response
- Improved Intestinal Innate Immunity
- Improved Intestinal Microenvironment
- Improved Intestinal Microflora Balance
- Improved Intestinal Mucosal Immunity
- Improved Intestinal Resistance to Salmonella Typhimurium
- Improved Management of Acute Gastroenteritis
- Improved Management of Acute Viral Diarrhea
- Improved Management of Diarrhea
- Improved Management of Rotavirus-Induced Diarrhea
- Improved Microbial Safety
- Improved Overall Gastric Symptoms
- Improved Overall Gastrointestinal Symptoms
- Improved Probiotic Functionality
- Improved Probiotic Product Stability
- Improved Recovery Rate
- Improved Recovery from Antibiotic-Associated Diarrhea
- Improved Recovery from Diarrhea
- Improved Recovery from Diarrhoea
- Improved Recovery of Intestinal Flora
- Improved Resistance to Foodborne Pathogens
- Improved Resistance to Intestinal Pathogens
- Improved Resistance to Intestinal Viral Infections
- Improved Salmonella Clearance
- Improved Specific IgA Response to Rotavirus
- Improved Survival Through Digestive Tract
- Improved Survival Under Gastrointestinal Challenges
- Improved Survival of Probiotic Bacteria
- Improved Symptom Resolution
- Improved Symptom Resolution Rate
- Improved Tolerance to High Doses of Probiotics
- Improved Water Absorption
- Increased Abdominal Symptoms in Children Taking Antibiotics
- Increased Adhesion to Enterocytes
- Increased Antibiotic Susceptibility
- Increased Antigen-Specific Immunoglobulin A
- Increased Bifidobacterium Persistence Duration
- Increased Bowel Movement Frequency
- Increased Clostridium perfringens Density
- Increased Cure Rate of Diarrhea by Day 3
- Increased Days Without Illness
- Increased Defecation Frequency
- Increased Diamine Oxidase Secretion
- Increased Diarrhea Incidence
- Increased Diarrhoea-Free Rate in Children After 72 Hours
- Increased Digestive Problem
- Increased Dispersal of Pathogenic Bacteria
- Increased EPEC Microcolony Size
- Increased Emesis
- Increased Fecal Bifidobacterial Populations
- Increased Fecal Calprotectin Levels
- Increased Fecal Excretion
- Increased Fecal Moisture Content
- Increased Fecal Output
- Increased Fecal Salmonella Shedding During Infection
- Increased Fecal Score
- Increased Fecal Secretory IgA Levels
- Increased Fever
- Increased Gastrointestinal Discomfort
- Increased Gastrointestinal Tract Colonization
- Increased IgA-Inducing Activity
- Increased Immunity to Gut-Acquired Infections
- Increased Incidence of Abdominal Symptoms
- Increased Interest in Probiotic Supplements
- Increased Intestinal Anti-E. coli IgA Antibody Responses
- Increased Intestinal Lactobacillus sakei Levels
- Increased Intestinal Motility
- Increased Intestinal Transit Rate
- Increased Persistence of Probiotics in Fecal Matter
- Increased Probiotic Bacteria Colonization
- Increased Probiotic Bacterial Count
- Increased Probiotic Bacterial Survival Through Upper Gastrointestinal Transit
- Increased Proliferation of Administered Bifidobacteria
- Increased Resistance to ETEC Infection
- Increased Resistance to Simulated Gastrointestinal Conditions
- Increased Salmonella Shedding
- Increased Specific IgA Levels to Rotavirus
- Increased Stool Frequency
- Increased Stool Looseness
- Increased Stool Volume
- Increased Total Bacterial Abundance
- Increased Total Fecal Bacterial Counts
- Lack of Protection of Intestinal Morphology Against DON
- Maintained Average Daily Gain in Diarrheic Calves
- Maintained Digestive Function
- Maintained Gastrointestinal Health
- Maintained Growth During Diarrheal Episodes
- Maintained Gut Homeostasis
- Maintained Healthy Gut Environment
- Maintained Intestinal Barrier Function
- Maintained Mucus Barrier Integrity
- Maintenance of Normal Intestinal Function
- Managed Gut Microbiota Disturbance
- Microbial Community Characterization
- Modulated Gut Microbial Diversity
- Necrotizing Enterocolitis Stage II
- No Change in Severe Diarrhea Incidence
- No Reduced Risk of Necrotizing Enterocolitis
- No Reduction in Gastrointestinal Infections
- No Significant Change in Duration of Gastrointestinal Symptoms
- No Significant Change in Gastrointestinal Symptoms
- No Worsening of Gastrointestinal Symptoms
- Normalized Stool Consistency
- Potential Probiotic Benefits
- Potential Probiotic Health Effects
- Presence of Viable L. acidophilus La-5 Strains in Feces
- Preserved Gastrointestinal Histological Structure
- Preserved Small Intestinal Villus Integrity
- Prevention of Diarrhea
- Prevention of Intestinal Infections
- Protected Enterocyte Structure
- Protection Against Brush Border Damage Induced by Bacteria
- Recovery of BB-12 from Feces
- Reduced Abdominal Cramping
- Reduced Abdominal Pain Intensity
- Reduced Abdominal Symptoms
- Reduced Acute Diarrhea Incidence
- Reduced Adhesion of Diarrheagenic Bacteria
- Reduced Adhesion of Foodborne Pathogens
- Reduced Anaerobic Gram-Negative Bacterial Counts
- Reduced Antibiotic-Associated Diarrhoea in Children
- Reduced Antiemetic Medication Use
- Reduced Appetite Changes
- Reduced Bacterial Translocation to Mesenteric Lymph Nodes
- Reduced Bowel Discomfort Symptoms
- Reduced Brachyspira hyodysenteriae Growth
- Reduced Campylobacter Coli Colonization
- Reduced Campylobacter Infection
- Reduced Campylobacter jejuni Colonization/Growth
- Reduced Campylobacter jejuni Survival
- Reduced Cell Attachment due to Enterovirulent Bacteria
- Reduced Chloride Level
- Reduced Clostridium Species Counts
- Reduced Colonic Transit Time
- Reduced Colonization by Diarrheagenic E. coli (EPEC)
- Reduced Colonization of Aeromonas Hydrophila in the Intestine
- Reduced Colonization of Cronobacter sakazakii in Enterocytes
- Reduced Day Care Absence
- Reduced Days with Diarrhea
- Reduced Diarrhea
- Reduced Diarrhea Duration
- Reduced Diarrhea Episodes
- Reduced Diarrhea Frequency
- Reduced Diarrhea Incidence
- Reduced Diarrhea Incidence in Day Care Centers
- Reduced Diarrhea Incidence in Offspring
- Reduced Diarrhea Rate
- Reduced Diarrhea Severity
- Reduced Diarrhea Symptoms
- Reduced Digestive Symptoms
- Reduced Duration of Acute Diarrhoea
- Reduced Duration of Acute Gastroenteritis
- Reduced Duration of Acute Infectious Diarrhea
- Reduced Duration of Anti-TB-associated Gastrointestinal Symptoms
- Reduced Duration of Diarrhea
- Reduced Duration of Diarrhea Episodes
- Reduced Duration of Gastrointestinal Adverse Symptom
- Reduced Duration of Gastrointestinal Symptoms
- Reduced Duration of Hospitalized Diarrhea in Children
- Reduced E. coli Adherence in Gut
- Reduced E. coli Concentration
- Reduced E. coli O157:H7 Colonization
- Reduced E. coli Pathogenic Effects
- Reduced EHEC Colonization
- Reduced EHEC Infection Symptoms
- Reduced ETEC Prevalence
- Reduced ETEC Toxin Levels
- Reduced ETEC-Induced Diarrhea
- Reduced ETEC-Positive Animals
- Reduced Electrolyte Level
- Reduced Enteritis Index
- Reduced Enterocyte Layer Colonization by Salmonella enterica
- Reduced Enterocyte Pathogen Load
- Reduced Enterohemorrhagic Escherichia coli Infection
- Reduced Enteropathogen Activity
- Reduced Enteropathogen Colonization
- Reduced Enteropathogen Growth
- Reduced Enteropathogen Presence in Enterocyte Layer
- Reduced Enteropathogenic Bacteria
- Reduced Enteropathogenic Burden
- Reduced Enteropathogenic Escherichia coli (EPEC) Adhesion
- Reduced Enteropathogenic Infection Risk
- Reduced Enterotoxigenic E. coli Adhesion
- Reduced Enterotoxigenic Escherichia coli Abundance
- Reduced Enterotoxin-Producing Bacillus Cereus Adhesion
- Reduced Epigastric Discomfort
- Reduced Episode Duration
- Reduced Escherichia Coli Levels
- Reduced Fecal Clostridium Levels
- Reduced Fecal Coliform Count
- Reduced Fecal Coliform Levels
- Reduced Fecal E. coli Populations
- Reduced Fecal Enterobacilli
- Reduced Fecal Enterococci
- Reduced Fecal Escherichia coli Count
- Reduced Fecal Excretion of Clostridium perfringens
- Reduced Fecal Salmonella Bacteria
- Reduced Fever
- Reduced Food Pathogen Activity
- Reduced Gastric Inflammation
- Reduced Gastroenteritis Episode
- Reduced Gastrointestinal Adverse Event
- Reduced Gastrointestinal Adverse Events
- Reduced Gastrointestinal Colonization of Listeria Monocytogenes
- Reduced Gastrointestinal Disease Incidence in Children
- Reduced Gastrointestinal Disease Symptoms
- Reduced Gastrointestinal Disorder Symptoms
- Reduced Gastrointestinal Disorders
- Reduced Gastrointestinal Infections
- Reduced Gastrointestinal Inflammation
- Reduced Gastrointestinal Leakage
- Reduced Gastrointestinal Pathogen Adhesion
- Reduced Gastrointestinal Symptom Severity
- Reduced Gastrointestinal Symptoms
- Reduced Gastrointestinal Tract Histological Damage
- Reduced Gut Damage
- Reduced Gut Disorders
- Reduced Harmful Gut Microbiota
- Reduced Harmful Intestinal Bacteria
- Reduced Hospitalization for Acute Gastroenteritis
- Reduced Hunger
- Reduced Impact of Gram-negative Microorganisms
- Reduced Incidence of Chronic Diarrhea
- Reduced Incidence of Diarrhea in Pigs
- Reduced Incidence of Diarrhoea in Children
- Reduced Incidence of Gastrointestinal Adverse Events
- Reduced Incidence of Gastrointestinal Tract Infection Symptoms
- Reduced Incidence of Infectious Diarrhoea
- Reduced Incidence of Loose or Watery Stools
- Reduced Incidence of Pediatric Diarrhea
- Reduced Incidence of Watery Diarrhea
- Reduced Infant Infections
- Reduced Infection Rate
- Reduced Inflammatory Response in Intestinal Cells
- Reduced Initial Mild Diarrhea
- Reduced Intestinal Infections
- Reduced Intestinal Inflammation Severity
- Reduced Intestinal Pathogen Bacterial Count
- Reduced Intestinal Pathogen Load
- Reduced Intestinal Pathogenic Bacteria
- Reduced Intestinal Pathogens
- Reduced Intestinal Pathology
- Reduced Intestinal Proinflammatory Cytokine Levels
- Reduced Intestinal Salmonella Burden
- Reduced Intestinal Tissue Injury
- Reduced Nausea Severity
- Reduced Nausea Symptom Severity
- Reduced Nausea and Vomiting
- Reduced Necrotising Enterocolitis
- Reduced Norovirus Multiplication
- Reduced Oral Rehydration Solution Intake in Non-rotavirus Diarrhea
- Reduced Oral Rehydration Solution Use
- Reduced Parental Absenteeism from Work
- Reduced Pathogen Count in Feces
- Reduced Pathogen Incidence
- Reduced Pathogenic Bacteria in Gut
- Reduced Pathogenic Contamination
- Reduced Pathogenic Microorganisms in the Intestine
- Reduced Pathogenicity of Escherichia coli
- Reduced Pathogenicity of S. Enteritidis
- Reduced Postweaning Diarrhea
- Reduced Potential Pathogens
- Reduced RV-Induced Diarrhea
- Reduced Recovery Time
- Reduced Recovery Time for Diarrhea
- Reduced Risk of Diarrhea on Day 4
- Reduced Risk of Prolonged Diarrhea
- Reduced Risk of Salmonella Infection
- Reduced Rotavirus Infection Incidence
- Reduced Rotavirus Infection Severity
- Reduced Rotavirus Shedding
- Reduced S. Typhi Growth
- Reduced Salmonella Activity
- Reduced Salmonella Attachment
- Reduced Salmonella Colonization
- Reduced Salmonella Enterica Invasion
- Reduced Salmonella Incidence
- Reduced Salmonella Infection Pathway
- Reduced Salmonella Population
- Reduced Salmonella Typhimurium Activity
- Reduced Salmonella Typhimurium Counts
- Reduced Salmonella enteritidis Colonization
- Reduced Salmonella sonnei Infection
- Reduced Salmonella typhimurium Adhesion
- Reduced Salmonella-Induced Interleukin-8 Production
- Reduced School Absence Days
- Reduced Secretion Consistency
- Reduced Severity of Acute Diarrhoea
- Reduced Shigella flexneri Infection Risk
- Reduced Stool Consistency
- Reduced Stool Output in Nonrotavirus Diarrhea
- Reduced Susceptibility to Foodborne Pathogens
- Reduced Symptom Duration
- Reduced Time Spent for Defecation
- Reduced Time to First Formed Stool
- Reduced Time to Symptom Resolution
- Reduced Total Bacterial Levels
- Reduced Vibrio Counts in Intestine
- Reduced Vomiting Duration
- Reduced Vomiting Incidence
- Reduced Watery Stools
- Regression of Gastrointestinal Disorders
- Relieved Gastrointestinal Symptoms
- Resolution of Diarrhea
- Resolved Moderate Diarrhea
- Shortened Diarrhea Duration
- Similar Rate of Diarrhea
- Stabilized Fecal Microbiota
- Stable Cytokine Levels in Gut-Associated Lymphoid Tissue
- Successful Gastrointestinal Tract Colonization
- Unchanged Gastrointestinal Symptoms
- Unchanged Incidence of Diarrhea
- Unchanged Intestinal Bacterial Concentrations
- Unchanged Severe Diarrhea
- Unchanged Stool Consistency or Bowel Frequency
- Unchanged Stool Frequency
- Viability of Probiotic Bacteria in Cheese
- Worsened Fecal Scores